Pillar 1 of 4
Insight on the product, the regulatory pathway, FDA engagement, market entry, and launch.
The Work
RGM helps companies translate scientific, clinical, quality, and commercial ambitions into practical regulatory and innovation strategies — improving the quality of the decision before submissions, investments, launches, or development commitments are already locked in.
Services Under This Pillar
Pathway analysis, product classification, lifecycle strategy, and FDA meeting strategy — from meeting type selection through briefing, question development, and feedback interpretation.
Learn More →Senior input on product concepts, target product profiles, development sequencing, evidence requirements, and the trade-offs between scientific ambition, regulatory feasibility, and commercial intent.
Learn More →Market-entry assessments, launch-readiness roadmaps, regulatory and quality requirement mapping, retailer considerations, and practical recommendations for commercialization.
Learn More →Translation of global product concepts into U.S.-appropriate regulatory, scientific, quality, claims, and commercial strategies.
Learn More →Switch feasibility assessment, evidence and consumer-behavior requirements, FDA engagement strategy, and ACNU-enabled innovation roadmaps.
Learn More →Product positioning, claims feasibility, evidence strategy, and regulatory considerations for the women's health category.
Learn More →21 CFR Part 111 gap assessment, specification review, label claim alignment, importer/manufacturer responsibility mapping, and quality readiness for launch.
Learn More →How We Engage
RGM engagements are designed around the decision the client needs to make — from focused, time-bound assessments to ongoing senior advisory support.
U.S. market-entry assessment
FDA meeting strategy & briefing development
Product classification & pathway analysis
Launch-readiness review
Fractional regulatory leadership
Innovation portfolio advisory
Multi-product lifecycle strategy
Switch & ACNU program leadership
More Pillars